COVID-19: all 7,774 studies

Page 62 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART TrialSuspendedNCT04482621Phase 2
• BIO 300 Oral Suspension in Previously Hospitalized Long COVID PatientsActive, not recruitingNCT04482595Phase 2
• SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRESCompletedNCT04482361
• Emotional Support and Stress Management in Patients Diagnosed With COVID-19Status unknownNCT04482023
• Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CTCompletedNCT04481620
• Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19Status unknownNCT04481477
• Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed DiagnosisStatus unknownNCT04480632Phase 2
• The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.CompletedNCT04480593Phase 2/3
• Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for SurgeryCompletedNCT04480580
• Does COVID-19 Pandemic Reduce In-hospital Mortality?CompletedNCT04480515
• Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 PatientsWithdrawnNCT04480411Not applicable
• Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic PatientsCompletedNCT04480398
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownNCT04480333Phase 1
• Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)TerminatedNCT04480138Phase 2
• Experience of an Emergency Intensive Care Unit During COVID-19 PandemicCompletedNCT04480060
• Obesity Surgery During 2020 Italian PandemicStatus unknownNCT04480034
• Microbial Infection and AMR in Hospitalized Patients With Covid 19Status unknownNCT04479982
• Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198CompletedNCT04479644Phase 1
• Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196CompletedNCT04479631Phase 1
• Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)CompletedNCT04479488
• The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19)CompletedNCT04479332Not applicable
• Decision Support System Algorithm for COVID-19 DiagnosisCompletedNCT04479319
• Post COVID-19 Functional Status in EgyptStatus unknownNCT04479293
• The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19CompletedNCT04479202Phase 4
• Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 PandemicCompletedNCT04479150
• Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of IstanbulCompletedNCT04479137
• The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of IstanbulCompletedNCT04479124
• Extracorporeal Blood Purification as a Treatment Modality for COVID-19CompletedNCT04478539
• SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral SheddingCompletedNCT04478019Early Phase 1
• Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe HypoxemiaTerminatedNCT04477954Phase 2
• Long-Term Experience and Health Effects of COVID-19CompletedNCT04477902
• Methodist Health System COVID-19 Patient RegistryCompletedNCT04477889
• Helmet Non-Invasive Ventilation for COVID-19 PatientsCompletedNCT04477668Not applicable
• Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory FailureCompletedNCT04477655Not applicable
• Abatacept for Patients With COVID-19 and Respiratory DistressWithdrawnNCT04477642Phase 1/2
• Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk GroupCompletedNCT04477473
• Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.CompletedNCT04477213
• Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19Status unknownNCT04477083Not applicable
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen RequirementCompletedNCT04476992Phase 1/2
• COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and InflammationActive, not recruitingNCT04476953Phase 2
• Detection of COVID-19 Subjects Using DiaNose Exhalation TestStatus unknownNCT04476927Not applicable
• Convalescent Plasma Treatment in COVID-19CompletedNCT04476888Not applicable
• European Pathology Laboratories and COVID-19CompletedNCT04476823
• Canakinumab MAP in COVID-19 Pneumonia With CRSNo longer availableNCT04476706
• Influence of Military Preventive Policy for reCruit Training on COVID-19 SeroconversionStatus unknownNCT04476680Not applicable
• Online Delivery of Psychotherapy, Tailored to Patients' Suffering from Mental Health Problems Due to COVID-19CompletedNCT04476667Not applicable
• Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) ProtocolCompletedNCT04476602
• Prognostication of Recovery in Early Disorders of Consciousness After COVID-19CompletedNCT04476589
• Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 AdultsTerminatedNCT04475991Phase 2
• Enzalutamide Treatment in COVID-19TerminatedNCT04475601Phase 2
• Can the Electronic Nose Smell COVID-19 Antibodies?CompletedNCT04475575Not applicable
• Can the Electronic Nose Smell COVID-19?CompletedNCT04475562Not applicable
• WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease SurveyStatus unknownNCT04475471
• LILLE COVID RESEARCH NETWORK (Covid-19)CompletedNCT04475211
• Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic PatientsCompletedNCT04475120Phase 2/3
• The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 PatientsCompletedNCT04475107Phase 2
• Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of AgeStatus unknownNCT04474457
• Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP)CompletedNCT04474444
• COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected PatientsStatus unknownNCT04474340Phase 1
• The COVID-19 PUI Reality Check (CPRC) StudyCompletedNCT04474288
• Follow-up of Critical COVID-19 PatientsStatus unknownNCT04474249
• Lung Ultrasound for COVID-19 Initial Triage and MonitoringCompletedNCT04474236
• Reducing Burnout Among Frontline Healthcare Workers During COVID-19CompletedNCT04474080Not applicable
• COVID-19 - Cytokine StormStatus unknownNCT04474067
• Stay Well at Home: a Text-messaging Study Social DistancingCompletedNCT04473599Not applicable
• COVID 19 Preventive Measures Among Mansoura Nursing StudentsCompletedNCT04473547
• Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19)CompletedNCT04473365
• COVID-19 Detection Tests in Different Body FluidsStatus unknownNCT04473352
• Efficacy of Iodine Complex Against COVID-19 PatientsStatus unknownNCT04473261Phase 1/2
• Spartan COVID-19 System: Evaluation of Clinical Sample CollectionCompletedNCT04473248Not applicable
• Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in MinnesotaWithdrawnNCT04473183
• Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19CompletedNCT04473170Phase 1/2
• COVID-19 in Patients With Anosmia in EgyptCompletedNCT04473157
• Immune Profiling of COVID19-patients Admitted to ICUStatus unknownNCT04473131
• Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 PatientsStatus unknownNCT04473118
• Optimising Resource Allocation Via Prediction of Outcomes for Covid-19CompletedNCT04473105
• DEFINE - Evaluating Therapies for COVID-19CompletedNCT04473053Phase 1/2
• Repeated Employee Testing for Understanding Our Recovery to NormalCompletedNCT04472793
• Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 PatientsStatus unknownNCT04472585Phase 1/2
• Expanded Access to Convalescent Plasma for Treatment of COVID-19No longer availableNCT04472572
• Frequency of Perforated Appendicitis in Times of COVID-19CompletedNCT04472052
• Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19CompletedNCT04472013
• Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled StudyStatus unknownNCT04471831Not applicable
• Locally Produced Cloth Face Mask and COVID-19 Like Illness PreventionStatus unknownNCT04471766Not applicable
• Italian Web-based Cross-sectional Survey on COVID-19CompletedNCT04471701
• Telemedicine in Outpatient Covid-19 PatientsStatus unknownNCT04471636Not applicable
• Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy VolunteersCompletedNCT04471519Phase 1/2
• An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 PatientsCompletedNCT04471051
• Changes in Cellular Immune Profile During COVID-19 InfectionSuspendedNCT04470999Not applicable
• Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?Status unknownNCT04470739Not applicable
• COVID-19 Infection at Samusocial in Paris: Descriptive and Serological SurveyCompletedNCT04470648
• Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 YearsCompletedNCT04470609Phase 1/2
• Evaluating Clinical Parameters of COVID-19 in PregnancyStatus unknownNCT04470583
• Relation Between Lab Finding and COVID-19 SeverityStatus unknownNCT04470557
• Role of Co-trimoxazole in Severe COVID-19 PatientsStatus unknownNCT04470531Phase 2
• COVID-19 IgG Antibodies in the Serum of Recovered PatientsStatus unknownNCT04470414
• Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19Status unknownNCT04470297Phase 2
• Elmo Respiratory Support Project - COVID-19CompletedNCT04470258Not applicable
• Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in IndiaStatus unknownNCT04469660
• COVID 19 Seroprevalence Amongst Healthcare Workers in JHAHStatus unknownNCT04469647

← COVID-19 overview